Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Obesity11722 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A01908 | 34565261 | Int J Food Sci Nutr | The effect of a Mediterranean diet vs. a low-fat diet on non-alcoholic fatty liver disease in children: a randomized trial. | 2021 | Details |
| A01919 | 34562443 | J Pediatr | The Prevalence of Elevated Alanine Aminotransferase Levels Meeting Clinical Action Thresholds in Children with Obesity in Primary Care Practice. | 2021 | Details |
| A01920 | 34561962 | J Diabetes Investig | Metabolic associated fatty liver disease is a risk factor for chronic kidney disease. | 2021 | Details |
| A01921 | 34561722 | Eur J Nutr | Effects of β-glucan, probiotics, and synbiotics on obesity-associated colitis and hepatic manifestations in C57BL/6J mice. | 2021 | Details |
| A01930 | 34558862 | Hepatol Commun | Risk of Cardiovascular Disease in Individuals With Nonobese Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A01931 | 34558856 | Hepatol Commun | Role of Cholesterol-Associated Steatohepatitis in the Development of NASH. | 2021 | Details |
| A01933 | 34558853 | Hepatol Commun | Independent Predictors of Mortality Among Patients With NAFLD Hospitalized With COVID-19 Infection. | 2021 | Details |
| A01934 | 34558849 | Hepatol Commun | Distinct Hepatic Gene-Expression Patterns of NAFLD in Patients With Obesity. | 2021 | Details |
| A01937 | 34558835 | Hepatol Commun | Ipragliflozin Improves the Hepatic Outcomes of Patients With Diabetes with NAFLD. | 2021 | Details |
| A01945 | 34557498 | Front Med (Lausanne) | Fecal Microbiota Transplantation as a Tool for Therapeutic Modulation of Non-gastrointestinal Disorders. | 2021 | Details |
| A01946 | 34557398 | Pediatr Gastroenterol Hepatol Nutr | The PNPLA3 rs738409 Variant but not MBOAT7 rs641738 is a Risk Factor for Nonalcoholic Fatty Liver Disease in Obese U.S. Children of Hispanic Ethnicity. | 2021 | Details |
| A01947 | 34557397 | Pediatr Gastroenterol Hepatol Nutr | Investigation of Thiol/Disulfide Balance in Obese Rats with Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A01949 | 34557366 | Cureus | The Troubling Link Between Non-alcoholic Fatty Liver Disease (NAFLD) and Extrahepatic Cancers (EHC). | 2021 | Details |
| A01952 | 34555422 | J Hepatol | NAFLD-driven HCC: Safety and efficacy of current and emerging treatment options. | 2021 | Details |
| A01955 | 34555255 | Liver Int | COVID-19, adaptative immune response and metabolic-associated liver disease. | 2021 | Details |
| A01957 | 34553836 | Obesity (Silver Spring) | Type 2 diabetes mellitus increases the risk of hepatic fibrosis in individuals with obesity and nonalcoholic fatty liver disease. | 2021 | Details |
| A01964 | 34550043 | Adipocyte | Sodium glucose cotransporter 2 inhibitor dapagliflozin depressed adiposity and ameliorated hepatic steatosis in high-fat diet induced obese mice. | 2021 | Details |
| A01966 | 34549558 | Adv Clin Exp Med | A novel therapeutic approach to NASH: Both polyethylene glycol 3350 and lactulose reduce hepatic inflammation in C57BL/6J mice. | 2021 | Details |
| A01968 | 34548787 | Clin Interv Aging | NAFLD in the Elderly. | 2021 | Details |
| A01972 | 34547171 | Liver Int | The role of hepatic lipid composition in obesity-related metabolic disease. | 2021 | Details |
| A01973 | 34546515 | Obes Surg | Changes in Total Homocysteine and Glutathione Levels After Laparoscopic Sleeve Gastrectomy in Children with Metabolic-Associated Fatty Liver Disease. | 2021 | Details |
| A01977 | 34543756 | Clin Res Hepatol Gastroenterol | Adipose tissue dysfunction and MAFLD in obesity on the scene of COVID-19. | 2021 | Details |
| A01979 | 34543610 | Lancet | Liver cirrhosis. | 2021 | Details |
| A01982 | 34543321 | PLoS One | Fatty liver index as a predictive marker for the development of diabetes: A retrospective cohort study using Japanese health check-up data. | 2021 | Details |
| A01985 | 34541964 | Expert Opin Pharmacother | Management of non-alcoholic fatty liver disease in patients with sarcopenia. | 2021 | Details |
| A01986 | 34540943 | Visc Med | Excess Body Weight and Metabolic (Dysfunction)-Associated Fatty Liver Disease (MAFLD). | 2021 | Details |
| A01987 | 34540134 | Kans J Med | Bariatric Metabolic Surgery Reduced Liver Enzyme Levels in Patients with Non-Alcohol Fatty Liver Disease. | 2021 | Details |
| A01999 | 34534894 | Clin Nutr | Dairy protein intake is inversely related to development of non-alcoholic fatty liver disease. | 2021 | Details |
| A02015 | 34530527 | Clin Mol Hepatol | Systematic review with meta-analysis: Non-alcoholic fatty liver disease and the association with pregnancy outcomes. | 2021 | Details |
| A02018 | 34529585 | Physiol Int | The "GG" genotype of rs26802 variant in the ghrelin gene is a potential protective factor against nonalcoholic fatty liver disease. | 2021 | Details |
| A02026 | 34527673 | Front Cell Dev Biol | Lack of miR-379/miR-544 Cluster Resists High-Fat Diet-Induced Obesity and Prevents Hepatic Triglyceride Accumulation in Mice. | 2021 | Details |
| A02027 | 34527094 | Gastroenterology Res | Non-Invasive Assessment of Liver Fibrosis and Steatosis in End-Stage Renal Disease Patients Undergoing Renal Transplant Evaluation. | 2021 | Details |
| A02028 | 34526911 | Front Physiol | Metabolic Changes of Hepatocytes in NAFLD. | 2021 | Details |
| A02032 | 34525124 | PLoS One | Required warfarin dose and time in therapeutic range in patients with diagnosed Nonalcoholic Fatty Liver Disease (NAFLD) or Nonalcoholic Steatohepatitis (NASH). | 2021 | Details |
| A02038 | 34523235 | Liver Int | Relationship between drinking frequency and fatty liver prevalence or incidence in Japanese undergoing health checkup in 2008-2019. | 2021 | Details |
| A02060 | 34516703 | Int J Clin Pract | Does naringenin supplementation improve lipid profile, severity of hepatic steatosis and probability of liver fibrosis in overweight/obese patients with NAFLD? A randomised, double-blind, placebo-controlled, clinical trial. | 2021 | Details |
| A02063 | 34515137 | J Innate Immun | The Role of Innate Immune Cells in Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A02067 | 34512784 | Evid Based Complement Alternat Med | Cinnamic Acid Ameliorates Nonalcoholic Fatty Liver Disease by Suppressing Hepatic Lipogenesis and Promoting Fatty Acid Oxidation. | 2021 | Details |
| A02080 | 34511460 | Georgian Med News | [METABOLIC FEATURES OF ADIPOSE TISSUE AND CLINICAL SIGNIFICANCE OF ADIPOKINS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (REVIEW)]. | 2021 | Details |
| A02081 | 34511367 | Obes Res Clin Pract | Accuracy of ultrasound diagnosis of nonalcoholic fatty liver disease in patients with classes II and III obesity: A pathological image study. | 2021 | Details |
| A02087 | 34509791 | Diabetes Metab Syndr | Serum microRNA-486-5p expression in obese Egyptian children and its possible association with fatty liver. | 2021 | Details |
| A02090 | 34509375 | Surg Obes Relat Dis | Bariatric surgery improves metabolic and nonalcoholic fatty liver disease markers in metabolically healthy patients with morbid obesity at 5 years. | 2021 | Details |
| A02096 | 34508671 | Lancet Gastroenterol Hepatol | Epidemiology, risk factors, social determinants of health, and current management for non-alcoholic fatty liver disease in sub-Saharan Africa. | 2021 | Details |
| A02097 | 34508669 | Lancet Gastroenterol Hepatol | Health-care provision and policy for non-alcoholic fatty liver disease in sub-Saharan Africa. | 2021 | Details |
| A02103 | 34506332 | Clin Transl Gastroenterol | The Protection Conferred by HSD17B13 rs72613567 Polymorphism on Risk of Steatohepatitis and Fibrosis May Be Limited to Selected Subgroups of Patients With NAFLD. | 2021 | Details |
| A02104 | 34506234 | Adipocyte | A novel immune-related genes signature after bariatric surgery is histologically associated with non-alcoholic fatty liver disease. | 2021 | Details |
| A02105 | 34505899 | Nephrol Dial Transplant | Prevalence of non-alcoholic fatty liver disease in patients with chronic kidney disease: a case-control study. | 2021 | Details |
| A02110 | 34503976 | Mol Pharmacol | Construction and Characterization of CRISPR/Cas9 Knockout Rat Model of Carboxylesterase 2a Gene. | 2021 | Details |
| A02112 | 34503151 | Cancers (Basel) | Host-Microbiota Interactions in Liver Inflammation and Cancer. | 2021 | Details |
| A02113 | 34502347 | Int J Mol Sci | Molecular Imaging of Brown Adipose Tissue Mass. | 2021 | Details |
| A02114 | 34502047 | Int J Mol Sci | Molecular and Pathophysiological Links between Metabolic Disorders and Inflammatory Bowel Diseases. | 2021 | Details |
| A02115 | 34501590 | Int J Environ Res Public Health | Open Issues in the Transition from NAFLD to MAFLD: The Experience of the Plinio Study. | 2021 | Details |
| A02117 | 34501231 | J Clin Med | Effects of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy on Non-Alcoholic Fatty Liver Disease: A 12-Month Follow-Up Study with Paired Liver Biopsies. | 2021 | Details |
| A02122 | 34498413 | Pediatr Obes | Recent advances in the epidemiology of nonalcoholic fatty liver disease in children. | 2021 | Details |
| A02123 | 34498307 | Phytother Res | The effect of pomegranate extract on anthropometric indices, serum lipids, glycemic indicators, and blood pressure in patients with nonalcoholic fatty liver disease: A randomized double-blind clinical trial. | 2021 | Details |
| A02124 | 34497708 | Ther Adv Endocrinol Metab | Therapeutic approaches for non-alcoholic steatohepatitis. | 2021 | Details |
| A02125 | 34497507 | Front Aging Neurosci | Cardiometabolic Modification of Amyloid Beta in Alzheimer's Disease Pathology. | 2021 | Details |
| A02128 | 34496884 | Lipids Health Dis | Metformin ameliorates maternal high-fat diet-induced maternal dysbiosis and fetal liver apoptosis. | 2021 | Details |
| A02129 | 34496264 | J Ethnopharmacol | Mechanism by which Eucommia ulmoides leaves Regulate Nonalcoholic fatty liver disease based on system pharmacology. | 2021 | Details |
| A02134 | 34493216 | BMC Nephrol | Association of elevated serum aminotransferase levels with chronic kidney disease measures: hispanic community health study/study of latinos. | 2021 | Details |
| A02135 | 34493137 | Expert Rev Gastroenterol Hepatol | Differences between current clinical guidelines for screening, diagnosis and management of nonalcoholic fatty liver disease and real-world practice: a targeted literature review. | 2021 | Details |
| A02137 | 34491886 | Gut Microbes | Associations of the gut microbiome with hepatic adiposity in the Multiethnic Cohort Adiposity Phenotype Study. | 2022 | Details |
| A02138 | 34491336 | J Clin Endocrinol Metab | Nonalcoholic Fatty Liver Disease in Women and Girls With Polycystic Ovary Syndrome. | 2022 | Details |
| A02140 | 34490362 | Front Cardiovasc Med | The Risk of Type 2 Diabetes and Coronary Artery Disease in Non-obese Patients With Non-alcoholic Fatty Liver Disease: A Cohort Study. | 2021 | Details |
| A02141 | 34490309 | Front Med (Lausanne) | Effects of Telemedicine on Obese Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. | 2021 | Details |
| A02142 | 34489524 | Int J Obes (Lond) | Leptin resistance before and after obesity: evidence that tissue glucose uptake underlies adipocyte enlargement and liver steatosis/steatohepatitis in Zucker rats from early-life stages. | 2021 | Details |
| A02144 | 34488621 | Mol Med | MiR-100 overexpression attenuates high fat diet induced weight gain, liver steatosis, hypertriglyceridemia and development of metabolic syndrome in mice. | 2021 | Details |
| A02145 | 34487087 | Acta Biomed | The Prevalence of the Different Components of the Metabolic Syndrome (MetS) in Obese Nondiabetic Children and Young Adolescents and their Anthropometric Data in Relation to Parents. | 2021 | Details |
| A02146 | 34486981 | Endocr Connect | Nonalcoholic steatohepatitis: global impact and clinical consequences. | 2021 | Details |
| A02150 | 34485686 | Mol Ther Oncolytics | Regulatory role and mechanism of m6A RNA modification in human metabolic diseases. | 2021 | Details |
| A02153 | 34484560 | Oxid Med Cell Longev | Dietary Valine Ameliorated Gut Health and Accelerated the Development of Nonalcoholic Fatty Liver Disease of Laying Hens. | 2021 | Details |
| A02155 | 34484304 | Front Genet | Genetic Polymorphism of Vitamin D Family Genes CYP2R1, CYP24A1, and CYP27B1 Are Associated With a High Risk of Non-alcoholic Fatty Liver Disease: A Case-Control Study. | 2021 | Details |
| A02160 | 34481454 | BMC Gastroenterol | Impact of dietary compositions and patterns on the prevalence of nonalcoholic fatty liver disease in Japanese men: a cross-sectional study. | 2021 | Details |
| A02162 | 34479517 | BMC Pediatr | Higher BMI predicts liver fibrosis among obese children and adolescents with NAFLD - an interventional pilot study. | 2021 | Details |
| A02170 | 34475908 | Pak J Med Sci | Frequency of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus and its associated risk factors. | 2022 | Details |
| A02174 | 34474519 | Endocrinol Metab (Seoul) | Increased Risk of Nonalcoholic Fatty Liver Disease in Individuals with High Weight Variability. | 2021 | Details |
| A02178 | 34473313 | Methods Mol Biol | Therapeutic Effects of Resveratrol on Nonalcoholic Fatty Liver Disease Through Inflammatory, Oxidative Stress, Metabolic, and Epigenetic Modifications. | 2022 | Details |
| A02180 | 34472680 | Diabetes Obes Metab | Associations of weight loss with obesity-related comorbidities in a large integrated health system. | 2021 | Details |
| A02183 | 34470931 | Nihon Yakurigaku Zasshi | [Development of liver organoids from NASH model mice and their application to drug discovery]. | 2021 | Details |
| A02185 | 34469884 | Dig Dis | Transaminase Concentrations Cannot Separate Non-Alcoholic Fatty Liver and Non-Alcoholic Steatohepatitis in Morbidly Obese Patients Irrespective of Histological Algorithm. | 2021 | Details |
| A02187 | 34469404 | J Clin Gastroenterol | Management of Cardiometabolic Complications in Patients With Nonalcoholic Fatty Liver Disease: A Review of the Literature With Recommendations. | 2021 | Details |
| A02188 | 34467980 | J Clin Endocrinol Metab | Metabolic Dysfunction-associated Fatty Liver Disease and Mortality Among Chinese Adults: a Prospective Cohort Study. | 2022 | Details |
| A02191 | 34466334 | Cureus | Effective Treatment of Nonalcoholic Fatty Liver Disease Using a Community-Based Weight Management Program. | 2021 | Details |
| A02192 | 34466320 | Cureus | The Effect of Empagliflozin on Liver Fat in Type 2 Diabetes Mellitus Patients With Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A02193 | 34466067 | Saudi J Biol Sci | Prevalence and predictors of non-alcoholic fatty liver disease in tertiary care hospital of Taif, Saudi Arabia: A retrospective study. | 2021 | Details |
| A02194 | 34465857 | Int J Obes (Lond) | Obese mice weight loss role on nonalcoholic fatty liver disease and endoplasmic reticulum stress treated by a GLP-1 receptor agonist. | 2021 | Details |
| A02195 | 34465807 | Sci Rep | Close association between non-alcoholic fatty liver disease and ossification of the posterior longitudinal ligament of the spine. | 2021 | Details |
| A02196 | 34464909 | Diabetes Metab Syndr | Retrospective analysis (2009-2017) of factors associated with progression and regression of non-alcoholic fatty liver disease (Hepatic steatosis) in patients with type 2 diabetes seen at a tertiary diabetes centre in Southern India. | 2021 | Details |
| A02199 | 34463983 | Periodontol 2000 | Periodontal disease-related nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: An emerging concept of oral-liver axis. | 2021 | Details |
| A02201 | 34462492 | Sci Rep | Deletion of RAGE fails to prevent hepatosteatosis in obese mice due to impairment of other AGEs receptors and detoxifying systems. | 2021 | Details |
| A02209 | 34459761 | Wiad Lek | ASSOCIATION ANALYSIS OF PIOGLITAZONE EFFECTIVENESS IN TREATMENT OF NAFLD PATIENTS WITH OBESITY AND PPARG RS1801282 (PRO12ALA) GENOTYPE. | 2021 | Details |
| A02216 | 34456329 | Med Sci Monit | A Review of the Increasing Prevalence of Metabolic-Associated Fatty Liver Disease (MAFLD) in Children and Adolescents Worldwide and in Mexico and the Implications for Public Health. | 2021 | Details |
| A02222 | 34454951 | J Pediatr | Prevalence and Clinical Significance of Autoantibodies in Children with Overweight and Obesity with Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A02224 | 34453963 | J Hepatol | Epidemiology and risk-stratification of NAFLD-associated HCC. | 2021 | Details |
| A02226 | 34453689 | Obes Surg | Correlation Between Sex Hormones and Non-alcoholic Fatty Liver Disease Before and After Laparoscopic Sleeve Gastrectomy. | 2021 | Details |
| A02227 | 34453648 | J Med Ultrason (2001) | The most appropriate region-of-interest position for attenuation coefficient measurement in the evaluation of liver steatosis. | 2021 | Details |
| A02231 | 34453052 | Nat Commun | The pesticide chlorpyrifos promotes obesity by inhibiting diet-induced thermogenesis in brown adipose tissue. | 2021 | Details |
| A02232 | 34450627 | J Mol Cell Biol | Benzo[a]pyrene stimulates miR-650 expression to promote the pathogenesis of fatty liver disease and hepatocellular carcinoma via SOCS3/JAK/STAT3 cascades. | 2021 | Details |
| A02234 | 34450194 | Prog Lipid Res | PARPs in lipid metabolism and related diseases. | 2021 | Details |
| A02237 | 34449768 | PLoS One | Association of IRS1 (Gly972Arg) and IRS2 (Gly1057Asp) genes polymorphisms with OSA and NAFLD in Asian Indians. | 2021 | Details |